SCHEMBL6155353

SCHEMBL6155353

COc1cc(N(C)C2CCN(C)CC2)ccc1C(N)=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP15 Q460N3 1/20 0.43
PARP10 Q53GL7 1/20 0.43
QPCT Q16769 1/20 0.41
QPCTL Q9NXS2 1/20 0.41
NEK2 P51955 1/20 0.41
ALDH1A1 P00352 1/20 0.41
GAA P10253 1/20 0.41
HTR2A P28223 1/20 0.41
HTR2C P28335 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
PDE7A Q13946 1/20 0.39
HTR4 Q13639 1/20 0.39
MEN1 O00255 1/20 0.39
LMNA P02545 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
TSHR P16473 1/20 0.39
CYP2C19 P33261 1/20 0.39
KMT2A Q03164 1/20 0.39
NSD2 O96028 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13046490 0.84 NSD2 (0.47) QPCTQPCTLALDH1A1GAAHTR2A
SCHEMBL6153634 0.84 PARP15 (0.44) PARP15PARP10QPCTALDH1A1L3MBTL1
SCHEMBL6156880 0.82 CHRM2 (0.54) QPCTALDH1A1HTR2AHTR2CL3MBTL1
SCHEMBL2826258 0.81 NSD2 (0.42) QPCTQPCTLALDH1A1GAAHTR2A
SCHEMBL2169887 0.78 NSD2 (0.42) QPCTQPCTLALDH1A1GAAHTR2A
SCHEMBL13803948 0.77 NSD2 (0.41) QPCTQPCTLALDH1A1GAAHTR2A
SCHEMBL12970697 0.75 LMNA (0.57) PARP15PARP10ALDH1A1GAAL3MBTL1
SCHEMBL6154425 0.74 EHMT2 (0.50) PARP15PARP10ALDH1A1GAAEHMT2
SCHEMBL12237795 0.72 PDK2 (0.47) HTR2AHTR2C
SCHEMBL4703621 0.71 NEK2 (0.61) NEK2TSHRKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050182040-A1 Benzamide derivatives DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2005-08-18 US disclosed
EP-1500643-A1 BENZAMIDE DERIVATIVES SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 2005-01-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050182040-A1 Benzamide derivatives ROCK1, ROCK2, NHERF1 PARP15 1230/4885PARP10 1211/4885QPCT 3847/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.